Aperture Sectors › Healthcare & Life Sciences › Medical robotics & devices
Medical robotics & devices funding
Medical robotics & devices
A sub-sector of Healthcare & Life Sciences. Each company counts once, in its main sub-sector.
35 rounds, $222M raised by 31 companies, Jan 2, 2023 to Nov 14, 2026, 0% of Healthcare & Life Sciences capital. Top three companies: Mendaera 33%, Carlsmed 24%, Shanmu SHANMU 7%.
| Company | HQ | Capital raised | Rounds | Exit |
|---|---|---|---|---|
| Mendaera | United States | $73M | 1 | — |
| Carlsmed | United States | $52M | 1 | — |
| Shanmu SHANMU | China | $15M | 2 | — |
| Mediintech | South Korea | $15M | 1 | — |
| Shyld AI | United States | $13M | 1 | — |
| Channel Robotics | United States | $10M | 2 | — |
| Bioliberty | United Kingdom | $8.2M | 1 | — |
| AiM Medical Robotics | United States | $8.1M | 1 | — |
| Glaud (GLOUD) | South Korea | $6.2M | 1 | — |
| Scalpel AI | United Kingdom | $4.9M | 1 | — |
| Custom Surgical | Germany | $4.1M | 1 | — |
| AIRS | South Korea | $3.6M | 1 | — |
| Surgical Automations | United States | $3.4M | 1 | — |
| Cobionix | Canada | $3M | 1 | — |
| Dentscape | United States | $1M | 1 | — |
| Rosota | South Korea | $970K | 1 | — |
| FoxEyes | United States | $540K | 1 | — |
| ROBO Medical | China | $0 | 2 | — |
| Pangce Medical (磅策医疗) | China | $0 | 2 | — |
| 景芮医疗 | China | $0 | 1 | — |
| Yangshan Medical | China | $0 | 1 | — |
| Weijing Medical | China | $0 | 1 | — |
| Chunfeng Huayu | China | $0 | 1 | — |
| Lingke Medical | China | $0 | 1 | — |
| Mengshi Technology | China | $0 | 1 | — |
| Company | Amount | Stage | Announced |
|---|---|---|---|
| Mendaera | $73M | Series B | Sep 26, 2024 |
| Carlsmed | $52M | Series C | Mar 18, 2024 |
| Shanmu SHANMU | $15M | Series A | May 6, 2026 |
| Mediintech | $15M | Series B | May 13, 2024 |
| Shyld AI | $13M | Seed | May 14, 2026 |
| Bioliberty | $8.2M | Series A | Mar 19, 2026 |
| AiM Medical Robotics | $8.1M | Series A | Sep 30, 2025 |
| Channel Robotics | $7.5M | Unlabeled | Jan 13, 2025 |
| Glaud (GLOUD) | $6.2M | Series A | May 8, 2025 |
| Scalpel AI | $4.9M | Unlabeled | Oct 31, 2024 |